Tolerance of normal tissues to radiation therapy: Ear;Dose de tolérance à l'irradiation des tissus sains: l'oreille

Cancer/Radiotherapie

Volumn 14, Issue 4-5, 2010, Pages 284-289

  Fleury, B ^a   Lapeyre, M ^b  

^a CENTRE LÉON BÉRARD   (France)

^b CENTRE JEAN PERRIN   (France)

Author keywords

Ear; Sensorineural hearing loss; Toxicity

Indexed keywords

CISPLATIN;

CANCER RADIOTHERAPY; COCHLEA; GROUPS BY AGE; HEAD AND NECK CANCER; HEARING; HUMAN; INNER EAR; NASOPHARYNX; PARANASAL SINUS; PAROTID GLAND; PERCEPTION DEAFNESS; PRIORITY JOURNAL; RADIATION DOSE; SHORT SURVEY;

ADULT; AGE FACTORS; AGING; COCHLEA; EAR; HEAD AND NECK NEOPLASMS; HEARING; HUMANS; MIDDLE AGED; RADIATION TOLERANCE; RADIOTHERAPY;

EID: 77955332924     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2010.02.011     Document Type: Short Survey

References (35)

1. International Nasopharynx Cancer Study Group: VUMCA I Trial. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. Int J Radiat Oncol Biol Phys 1996;35(3):463-9.
2. Anteunis L.J., Wanders S.L., Hendriks J.J., Langendijk J.A., Manni J.J., de Jong J.M. A prospective longitudinal study on radiation-induced hearing loss. Am J Surg 1994, 168:408-411.
3. Bhandare N., Antonelli P.J., Morris C.G., Malayapa R.S., Mendenhall W.M. Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys 2007, 67:469-479.
4. Bhide S.A., Harrington K.J., Nutting C.M. Otological toxicity after postoperative radiotherapy for parotid tumours. Clin Oncol (R Coll Radiol) 2007, 19:77-82.
5. Chan S.H., Ng W.T., Kam K.L., Lee M.C., Choi C.W., Yau T.K., et al. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis. Int J Radiat Oncol Biol Phys 2009, 73:1335-1342.
6. Chen M., Hayman J.A., Ten Haken R.K., Tatro D., Fernando S., Kong F.M. Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 nonsmall-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation?. Int J Radiat Oncol Biol Phys 2006, 64:120-126. [10.1016/j.ijrobp.2005.06.029].
7. Chen W.C., Jackson A., Budnick A.S., Pfister D.G., Kraus D.H., Hunt M.A., et al. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer 2006, 106:820-829.
8. Chen W.C., Liao C.T., Tsai H.C., Yeh J.Y., Wang C.C., Tang S.G., et al. Radiation-induced hearing impairment in patients treated for malignant parotid tumor. Ann Otol Rhinol Laryngol 1999, 108:1159-1164.
9. Emami B., Lyman J., Brown A., Coia L., Goitein M., Munzenrider J.E., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:109-122.
10. Grau C., Moller K., Overgaard M., Overgaard J., Elbrond O. Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1991, 21:723-728.
11. Grau C., Overgaard J. Postirradiation sensorineural hearing loss: a common but ignored late radiation complication. Int J Radiat Oncol Biol Phys 1996, 36:515-517.
12. Herrmann F., Dorr W., Muller R., Herrmann T. A prospective study on radiation-induced changes in hearing function. Int J Radiat Oncol Biol Phys 2006, 65:1338-1344.
13. Hitchcock Y.J., Tward J.D., Szabo A., Bentz B.G., Shrieve D.C. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 2009, 73:779-788.
14. Ho W.K., Wei W.I., Kwong D.L., Sham J.S., Tai P.T., Yuen A.P., et al. Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: a prospective study. Head Neck 1999, 21:547-553.
15. Hoistad D.L., Ondrey F.G., Mutlu C., Schachern P.A., Paparella M.M., Adams G.L. Histopathology of human temporal bone after cis-platinum, radiation, or both. Otolaryngol Head Neck Surg 1998, 118:825-832.
16. Honore H.B., Bentzen S.M., Moller K., Grau C. Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation. Radiother Oncol 2002, 65:9-16.
17. Jereczek-Fossa B.A., Zarowski A., Milani F., Orecchia R. Radiotherapy-induced ear toxicity. Cancer Treat Rev 2003, 29:417-430.
18. Johannesen T.B., Rasmussen K., Winther F.O., Halvorsen U., Lote K. Late radiation effects on hearing, vestibular function, and taste in brain tumor patients. Int J Radiat Oncol Biol Phys 2002, 53:86-90.
19. Kopelman J., Budnick A.S., Sessions R.B., Kramer M.B., Wong G.Y. Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing. Laryngoscope 1988, 98:858-864.
20. Kwong D.L., Wei W.I., Sham J.S., Ho W.K., Yuen P.W., Chua D.T., et al. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment. Int J Radiat Oncol Biol Phys 1996, 36:281-289.
21. Liberman P.H., Schultz C., Gomez M.V., Carvalho A.L., Pellizzon A.C., Testa J.R., et al. Auditory effects after organ preservation protocol for laryngeal/hypopharyngeal carcinomas. Arch Otolaryngol Head Neck Surg 2004, 130:1265-1268.
22. Linskey M.E., Johnstone P.A. Radiation tolerance of normal temporal bone structures: implications for gamma knife stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2003, 57:196-200.
23. Low W.K., Toh S.T., Wee J., Fook-Chong S.M., Wang D.Y. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study. J Clin Oncol 2006, 24:1904-1909.
24. Merchant T.E., Gould C.J., Xiong X., Robbins N., Zhu J., Pritchard D.L., et al. Early neuro-otologic effects of three-dimensional irradiation in children with primary brain tumors. Int J Radiat Oncol Biol Phys 2004, 58:1194-1207.
25. Miettinen S., Laurikainen E., Johansson R., Minn H., Laurell G., Salmi T.T. Radiotherapy enhanced ototoxicity of cisplatin in children. Acta Otolaryngol Suppl 1997, 529:90-94.
26. Nutting C.M., Rowbottom C.G., Cosgrove V.P., Henk J.M., Dearnaley D.P., Robinson M.H., et al. Optimisation of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal, and intensity-modulated techniques. Radiother Oncol 2001, 60:163-172.
27. Ondrey F.G., Greig J.R., Herscher L. Radiation dose to otologic structures during head and neck cancer radiation therapy. Laryngoscope 2000, 110:217-221.
28. Pan C.C., Eisbruch A., Lee J.S., Snorrason R.M., Ten Haken R.K., Kileny P.R. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 2005, 61:1393-1402.
29. Société française de radiothérapie oncologique. Guide des procédures de radiothérapie externe 2007. Cancer Radiother 2008;12:143-313.
30. van der Putten L., de Bree R., Plukker J.T., Langendijk J.A., Smits C., Burlage F.R., et al. Permanent unilateral hearing loss after radiotherapy for parotid gland tumors. Head Neck 2006, 28:902-908.
31. Walker D.A., Pillow J., Waters K.D., Keir E. Enhanced cis-platinum ototoxicity in children with brain tumours who have received simultaneous or prior cranial irradiation. Med Pediatr Oncol 1989, 17:48-52.
32. Young Y.H., Ko J.Y., Sheen T.S. Postirradiation vertigo in nasopharyngeal carcinoma survivors. Otol Neurotol 2004, 25:366-370.
33. Zabel A., Milker-Zabel S., Huber P., Schulz-Ertner D., Schlegel W., Wannenmacher M., et al. Fractionated stereotactic conformal radiotherapy in the management of large chemodectomas of the skull base. Int J Radiat Oncol Biol Phys 2004, 58:1445-1450.
34. Zuur C.L., Simis Y.J., Lamers E.A., Hart A.A., Dreschler W.A., Balm A.J., et al. Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors. Int J Radiat Oncol Biol Phys 2009, 74:490-496.
35. Zuur C.L., Simis Y.J., Lansdaal P.E., Hart A.A., Rasch C.R., Schornagel J.H., et al. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis. Int J Radiat Oncol Biol Phys 2007, 68:1320-1325.